HE GPi has been of interest to neurosurgeons in the treatment of PD since the middle of the 20th century. 23 Initially, the target was located in the anterior and mediodorsal portion of the nucleus, but these medial pallidotomies only had an effect on rigidity and not on tremor. In 1956, Leksell moved the target toward the ventroposterolateral portion of the GPi, and equal effects on tremor, rigidity, and bradykinesia were reported. In 1992, Laitinen and colleagues 24 published the results of a large series of ventroposterolateral pallidotomies, which had been undertaken over an extended period of time. The results showed that this procedure gave long-lasting relief from akinesia and rigidity; other authors have since confirmed the relevance of the lesion.
ries of ventroposterolateral pallidotomies, which had been undertaken over an extended period of time. The results showed that this procedure gave long-lasting relief from akinesia and rigidity; other authors have since confirmed the relevance of the lesion.
After the discovery that high-frequency DBS has the same effect on symptoms as lesions but with fewer complications, the possibility of adjusting the effect over time and the chance of performing bilateral surgery led Siegfried to become the first to perform chronic pallidal electrostimulation in 1994. 34 Several reports have appeared on the effect of pallidal stimulation. As shown in a recent study, 26 it is difficult to interpret the results because of several factors, and large studies with long-term follow-up review are lacking. In general, the reports agree that there is a strong postoperative drug dependency, whereas drug-related side effects, more specifically dyskinesias, are directly counteracted by the stimulation.
In January 1996 we embarked on a technique of stereotactic surgery performed in patients with advanced PD. Because authors of several studies had reported beneficial effects of unilateral pallidotomy on parkinsonian symptoms 7, 8, 23, 24 and because DBS had proved to have fewer complications, 35 we decided to start with unilateral pallidal stimulation in selected patients. In previous studies we reported on cognitive outcomes 41 and changes in the quality of life 40 following unilateral pallidal stimulation in patients with PD.
In this report we prospectively analyze the long-term effects of unilateral pallidal stimulation on motor function. cal findings consistent with idiopathic PD accompanied by asymmetric distribution of symptoms and, despite optimal pharmacological treatment, severe response fluctuations and/or dyskinesias. A good initial response to levodopa was an absolute criterion. The one exception to this was the inclusion of patients who demonstrated levodopa-resistant rest tremor. Exclusion criteria included significant atrophy, multiple white matter lesions, or other focal brain abnormalities on MR images; parkinsonism due to known causative factors; Hoehn and Yahr Stage V at the best moment of the day; a score less than 24 on the Mini-Mental State Examination; psychosis; and general contraindications for surgery such as severe hypertension or blood coagulation disorders.
Surgical Procedure
Stereotactic surgery was performed using local anesthesia and the Leksell G frame after overnight withdrawal of antiparkinsonian drugs. The target was chosen in the external segment of the GPi with the following coordinates: 18 to 22 mm lateral to the anterior commissure-posterior commissure line, 4 mm anterior to the midcommissural point, and 2 mm inferior to the intercommissural line. In the first 10 patients the target was defined using both computerized tomography scanning and ventriculography. It became clear that target calculation performed using ventriculography added no extra value to target calculation performed using computerized tomography scanning alone, and we therefore decided to omit the ventriculography measurement in the remaining patients.
After making a precoronal burr hole, a rigid monopolar test-stimulation electrode (diameter 1.8 mm with a 2-mm naked tip, model 3101-2; Radionics, Ghent, Belgium) was introduced 6 mm above the presumed target. Stimulation was initiated with a frequency of 100 Hz and a stimulus duration of 0.1 msec, and it was continued stepwise every 2 mm, until 4 mm below the target. At each step the stimulus intensity was increased at increments of 0.5 V until the desired response was achieved or until unwanted side effects occurred. At each point of the test stimulation, the clinical response was evaluated by one neurologist (C.v.d.L.) blinded to the presence of the stimulation. The following clinical parameters were assessed using the UPDRS: tremor (if present) and rigidity in all four extremities; rapid finger movements; closing and opening of the hands; and dorsiflexion and plantar flexion of the feet and leg movements. If a clinical response was not present at or several millimeters below the target, the electrode was withdrawn and a second target through a different trajectory-2 mm anterior, posterior, medial, or lateral to the initial target-was chosen. If necessary, additional adjacent trajectories were selected. After determination of the optimal stimulation site, the monopolar electrode was replaced by the final quadripolar electrode (model 3387; Medtronic, Kerkrade, The Netherlands), with the second deepest pole at the level of the best clinical result. At the level of the burr hole, the electrode was fixed with methyl methacrylate and connected to an extension cable, which was externalized approximately 7 cm from the burr hole and connected to an external pulse generator (model 3625; Medtronic). After 1 week of evaluation with test stimulation had shown a clear effect on parkinsonian symptoms, a second operation was performed while the patient was in a state of general anesthesia for the subcutaneous implantation of the pulse generator (Itrel 2 model 7425 in 13 patients, and Itrel 2 model 7424 in the other 13 patients [Medtronic]).
Clinical Evaluation
Motor performance was evaluated using Part III, dyskinesias using Part IVa, and motor fluctuations using Part IVb of the UPDRS. 11 Preoperative UPDRS Part III assessments were conducted during the best on-medication state (on state) and the practically defined off-medication state (off state), as described in the Core Assessment Program for Intracerebral Transplantations in patients with PD. 25 Postoperative UPDRS Part III scores were evaluated during the best on and the practically defined off states with the stimulator on. For motor subscores the following questions from Part III were used: for rest tremor, Question 20 (maximum score 26); for rigidity, Question 22 (maximum score 20); for bradykinesia, Question 31 (maximum score 4); for akinesia, Questions 23 through 26 (maximum score 32); for gait, Question 29 (maximum score 4); and for freezing, Question 14 of Part II (maximum score 4). Dyskinesias and the daily appearance and predictability of off periods were evaluated using UPDRS Part IVa (dyskinesias; maximum score 13) and Part IVb (motor fluctuations; maximum score 7) scores both preoperatively and postoperatively with the stimulator on.
Medication Use
Medication intake was defined by the levodopa equivalent dose, which equals 100 mg levodopa or 133 mg levodopa modified-release preparations, or 1 mg pergolide, 10 mg bromocriptine, 1 mg cabergoline, 6 mg ropinirole, 1 mg lisuride, or 20 mg apomorphine.
Statistical Analysis
Data are presented as mean values Ϯ SDs. Changes between preoperative baseline, 3-month follow-up, and longterm follow-up values were analyzed using the paired Student t-test and the Wilcoxon signed-rank test.
This was repeated for both off and on states and for both sides (contralateral and ipsilateral) in each clinical parameter. Differences in follow-up values, compared with baseline values in the off state were compared with the same differences in the on state by applying repeated-measures analysis of variance, in which double paired t-tests are performed. Triple paired t-tests are also performed in this way, when the difference between contralateral and ipsilateral sides were compared over time in both the off and on state. Along with all these paired t-tests a more comprehensive analysis was performed in which the patient' s linear changes over time were expressed as one overall parameter. The calculation of the ordinary linear slope over time was complicated by the variable moment at which long-term followup results were measured: this could vary between 6 and 49 months after the operation. Weights found in unequal-distances first-order orthogonal polynomials were used to calculate individual linear slopes over time. Next, mean linear slopes in contralateral measurements, averaged for both the off and on states of the patients, were compared with those in ipsilateral measurements by means of the paired Student t-test and also by the Wilcoxon signed-rank test. To assess the relationship between preoperative differences in contralateral and ipsilateral scores and linear-slope differences between the same scores the Pearson correlation coefficient was used. To control for both patient age and sex, a regression analysis was performed to test the statistical significance of this relationship by means of its partial standardized regression or ␤ coefficient. A probability value less than 0.05 is considered to be statistically significant. All data were analyzed using a commercially available statistical software program (SPSS-pc, version 11.0.1; SPSS Inc., Chicago, IL).
Results
Twenty-six patients (20 men and six women) were included in this study. The mean age of these patients at the time of diagnosis was 43.1 Ϯ 10.5 years and the mean age at the time of surgery was 56.2 Ϯ 8.6 years. Patient profiles are listed in Table 1 . The side chosen for stimulation was either contralateral to the side affected or, if both sides were affected, contralateral to the more affected side.
The mean number of trajectories necessary to find an optimal clinical result during test stimulation was 2.44 (range 1-9 trajectories). No incidence of bleeding or serious side effects was encountered. Four patients displayed confusion for a maximum of 3 days after the electrode implantation. One patient suffered pain due to traction on the extension cable after implantation of the pulse generator; the pain disappeared after an Itrel augmentation procedure.
Results are presented 3 months after surgery and at longterm follow-up review, which occurred at a mean of 32.7 months (range 6-49 months).
Overall Effect on Motor Function
At 3 months postoperatively, significant improvements were found in global lateral motor symptoms, as well as in body bradykinesia and gait, during off and on states ( Table  2) . Freezing did not improve significantly. For all these symptoms, with the exception of akinesia, the improvement was significantly more pronounced while the patient was in the on state than in the off state (0.001 Ͻ p Ͻ 0.014). The total UPDRS Part III score did decrease by 50.7% (from 26.5 Ϯ 9.2 to 13.1 Ϯ 6.1) in the off state and by 55.4% (from 10.6 Ϯ 6.3 to 4.7 Ϯ 4.4) in the on state (p Ͻ 0.001). These differences in effect between the off and on states were most pronounced for body bradykinesia (p Ͻ 0.001; difference was 65.2% [from 2.7 Ϯ 0.8 to 0.9 Ϯ 0.7] in the off state and Ϫ81.2% [from 0.6 Ϯ 0.7 to 0.1 Ϯ 0.3] in the on state) and for gait (p = 0.005; difference was Ϫ49.3% [from 2.6 Ϯ 1.1 to 1.3 Ϯ 0.6] in the off state and Ϫ57.2% [from 1.1 Ϯ 0.8 to 0.5 Ϯ 0.6] in the on state).
There was a pronounced improvement in dyskinesias, with a decrease of 75% (from 3.7 Ϯ 2.5 to 0.9 Ϯ 1.1) in the UPDRS Part IVa score and a clear reduction in motor fluctuations, with a decrease of 54.7% (from 3.3 Ϯ 1.3 to 1.5 Ϯ 1.3 ) in the UPDRS Part IVb score.
At long-term follow-up review, there was a significant worsening of lateral symptoms, body bradykinesia, freezing, and gait when scores were compared with 3-month follow-up scores. Compared with baseline, the only significant change in the off state was a worsening of the score for freezing: 46.2% (from 2 Ϯ 1.1 to 2.9 Ϯ 1.1). Also in the on state there was no significant improvement in any item compared with baseline scores. On the contrary, there was a significant worsening of the UPDRS Part III total score 
Comparison of Contralateral and Ipsilateral Effects of Stimulation
At 3 months postoperatively, there was a statistically significant change between contralateral and ipsilateral improvements in motor function in the off state (Table 3) . During the off state the change in the UPDRS Part III score was Ϫ48.6% (from 18.5 Ϯ 4.9 to 9.5 Ϯ 3.8) on the contralateral side and Ϫ55.8% (from 13 Ϯ 5.7 to 5.8 Ϯ 3.4) on the ipsilateral side (p = 0.009). During the on state, the improvements were clearly more pronounced on the side contralateral to the stimulation, with a decrease of 74.4% (from 7.8 Ϯ 3.8 to 2 Ϯ 2.1) in the contralateral UPDRS Part III score, and 27.7% (from 4.6 Ϯ 3.4 to 3.3 Ϯ 3) in the ipsilateral score (p = 0.001 for the difference between on and off states).
At long-term follow-up review, this difference in sides in the on state was even more pronounced, with a decrease in the contralateral UPDRS Part III score of 4.9% (from 7. any lateral motor symptom in the off state, either ipsilaterally or contralaterally. Table 4 shows the means, SDs, and score ranges for the linear slopes in the UPDRS Part III for both contralateral and ipsilateral sides for both off and on states in the 26 patients. Using the paired t-test in both the off and on state, patients scored preoperatively higher on the contralateral side than on the ipsilateral one (p Ͻ 0.001). Averaging over both states there was still a statistically significant difference in the contralateral side, compared with the ipsilateral side, in baseline UPDRS Part III scores (p Ͻ 0.001). The mean difference between sides for all patients was 4.37 Ϯ 2.95 (range Ϫ0.5-11.5). Using the paired t-test there was no significant difference between the slopes of the contralateral and ipsilateral sides in the off state (p = 0.321), but there was a difference in the on state (p Ͻ 0.001). Averaging over both states there was still a statistically significant difference between the contralateral and ipsilateral sides in UPDRS Part III progression in time (p Ͻ 0.001): on the contralateral side the patient fared better over time due to the stimulation.
Regression analysis can be used to investigate the possible predictive power of the preoperative UPDRS Part III scores for the individual linear slope progression in these scores. Calculating the Pearson correlation coefficient between slope progression and the preoperative difference between contralateral and ipsilateral scores gave a statistically significant negative correlation coefficient of Ϫ0.421 (p = 0.016).
Standardizing for age and sex the ␤ coefficient of preoperative scores and slope progression scores remained statistically significant (␤ = Ϫ0.389, p = 0.049). Thus the larger the preoperative difference between scores on the contralateral and ipsilateral sides, the higher the linear progression difference between these sides will be.
Medication Use
It was not our aim to keep the medication regimen unchanged postoperatively, as described by the Core Assessment Program for Intracerebral Transplantations in patients with PD. In accordance with the patient' s clinical condition, we first optimized the stimulation parameters and then adjusted medication use.
The mean levodopa equivalent dose did not change significantly after 3 months. It increased significantly by 53% (from 788 to 1212 mg) at the long-term follow-up review.
Stimulation Settings
At 3 months, 14 patients received stimulation delivered in a monopolar manner, compared with 15 patients at longterm follow-up review. At 3 months, the mean voltage was 2.6 V (range 1-4 V), the mean frequency was 141 Hz (range 130-185 Hz), and the mean pulse width was 213 sec (range 120-300 sec). At long-term follow-up review, the mean voltage was 3.3 V (range 2-6 V), with a mean frequency of 135 Hz (range 130-185 Hz) and a mean pulse width of 234 sec (range 120-450 sec).
Discussion
The results of this study show that there was a clear effect of unilateral pallidal stimulation on contralateral and ipsilateral motor function, body bradykinesia, and gait in the off and on states, as well as on dyskinesias and motor fluctuations, at short-term (3-month) follow-up review in selected patients. At long-term follow up, the only improvement worth mentioning was in contralateral tremor and rigidity during the on phase.
Our short-term motor results (except for freezing in the off state) are better than those reported in a recently pub- lished study in which a 1-year follow-up review of unilateral pallidal stimulation is described. 26 This might be explained by patient selection. The mean preoperative total UPDRS Part III score under off-medication conditions in our study was 26.5 Ϯ 9.2 compared with 57.2 Ϯ 13.7 in the other study, and the mean preoperative UPDRS Part III score under on-medication conditions is 10.6 Ϯ 6.3 compared with 29.1 Ϯ 6.5. Moreover, our patients were selected on the basis of an asymmetric distribution of symptoms, which is illustrated by the mean difference between sides, which is 4.37 Ϯ 2.95. The higher this score is, the higher the preoperative differences in sides. The statistically significant negative Pearson correlation coefficient of Ϫ0.421 (p = 0.016), calculated between slope progression and preoperative UPDRS Part III scores, means that the higher the difference between contralateral and ipsilateral UPDRS Part III scores, the larger the difference between the contralateral and ipsilateral effect of stimulation will be. In other words, the less the ipsilateral side is affected preoperatively, the more the patient will benefit from the stimulation ipsilaterally.
Our long-term results are worse for any motor item compared with the results of the aforementioned study. 26 The change in the total UPDRS Part III off-medication score at long-term review was 8.3% in our study, compared with Ϫ38.3% in the other study, and the respective changes in UPDRS Part III on scores were 40.2 compared with Ϫ28.6%. The most pronounced difference is seen on the freezing score obtained in the on state: 172.7 compared with Ϫ16.5%. These huge differences at long-term review may be explained by the difference in follow-up periods: 21 patients in our study were followed for longer than 24 months (maximum 49 months), compared with 12 months in the other study. These results suggest that the short-term positive motor effect of unilateral pallidal stimulation declines progressively over time. This might be explained as follows. First of all, at short term, there might be a micropallidotomy effect. It seems to us unlikely, however, that this is still the case at 3 months, because in many patients we saw a worsening of symptoms when the stimulator was switched off after 3 months. Furthermore, disease progression might lead to a worsening of symptoms that cannot be counteracted by stimulation. At long-term review, there was
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Unilateral * The slopes are calculated through three measurements in time (preoperatively, at 3 months postoperatively, and at long-term follow-up review). A lower slope score stands for a relative improvement in the clinical condition, a zero slope stands for " no change," and a higher slope for a clinical deterioration. a significant increase in the mean stimulation voltage of 23.3% (2.6 compared with 3.3 V) in our study, with an insignificant increase in pulse width. The increase in medication was 53.8% (levodopa equivalent dose 821 compared with 1212 mg). This means that the effect of the stimulation was limited, and that an important increase in medication was necessary.
The results of this study confirm that stimulation of the GPi is a safe procedure. In a previous study we reported on cognitive outcome after unilateral pallidal stimulation. 41 No significant deterioration in cognitive status was seen. In the 1-year follow-up study mentioned previously, no changes in cognitive function were reported after 12 months.
In our study no stimulation-dependent behavioral changes were noted. This is in contrast to our experience with bilateral STN stimulation. In a significant number of patients who underwent bilateral STN stimulation for advanced PD in our hospital, voltage-dependent behavioral disinhibition was noticed and was sometimes accompanied by hypersexuality and aggression (report in progress). Comparable behavioral changes have been reported by other groups. 10, 33, 37 This may lead to the question of whether pallidal stimulation might be preferable in some patients who are prone to behavioral changes, despite the superior effect of STN stimulation on motor symptoms. 6, 16, 19, 21, 30, 31, 39 Particularly for patients who have undergone a pallidotomy and in whom motor symptoms on the side ipsilateral to the lesion or axial problems like gait freezing develop, the question could arise: would the patient be better off with contralateral unilateral pallidal stimulation or with bilateral STN stimulation? A bilateral pallidotomy bears too many risks, of which speech and psychiatric disturbances are the most frequent. 3, 5, 12, 17, 28 A unilateral STN stimulation after pallidotomy is not an option because of conflicting postoperative medication requirements: in general STN stimulation demands a postoperative reduction of medication to avoid dyskinesias, 29 whereas for the side contralateral to the pallidotomy the patient generally remains strongly dependent on medication. 27 Moreover, problems with gait freezing and falling have been reported after unilateral STN stimulation in patients with a unilateral pallidotomy. 36 If one has to consider the risks of bleeding, which theoretically increase when more electrodes are implanted, a unilateral pallidal stimulation would be the better option. When the risks of behavioral changes are taken into account, one would again choose unilateral pallidal stimulation. Our results demonstrate that, despite its safety, unilateral pallidal stimulation is not a good treatment option for patients with advanced PD because of the unsatisfactory motor effects at long-term review, even on the side contralateral to the side of stimulation.
It is interesting to note that we found similarities between the long-term effects of unilateral pallidal stimulation and unilateral pallidotomy. Hariz and Bergenheim 15 reviewed a 10-year follow up of patients who underwent the Leksell posteroventral pallidotomy for PD. The only symptoms on which the effect was lasting were tremor and dyskinesias. Most patients exhibited a gradual recurrence of axial and akinetic symptoms. Similarly Baron, et al., 1 Pal, et al., 32 and Gregory 14 demonstrated that initial improvements in contralateral dyskinesia and tremor were preserved after unilateral pallidotomy, whereas the improvements in most other deficits disappeared during follow-up periods lasting 3, 2, and 4 years, respectively. Valldeoriola and colleagues 38 and Fine, et al., 13 found that significant early improvements in off-period contralateral signs of parkinsonism were sustained for 4 and 5.5 years, respectively, whereas early benefits observed in axial symptoms and motor fluctuations waned with time.
The underlying mechanism of the effects of pallidal surgery is not clearly understood. 9 Moreover, the effects of stimulation both on parkinsonism and dyskinesias has been shown to vary with the site of stimulation within the pallidal complex: more ventral stimulation has a better effect on dyskinesias at the cost of the effect on akinesia, whereas more dorsal stimulation has a better effect on akinesia at the cost of dyskinesias. 2, 20 It seems as if a compromise has to be found concerning which symptoms will be ameliorated and which will not.
In the case of posteroventral pallidal stimulation, which we performed in this study, this compromise led to favorable results for some time, as long as the akinetic symptoms could be ameliorated by increasing the medication. Levodopa can be increased to higher levels after pallidal surgery because medication-induced dyskinesias are counteracted by the surgery. This rise in medication, however, has its limits, whereas akinetic symptoms progressively decline due to the natural course of the disease.
We consider it unlikely that patient selection led to poor results in our study. A preoperative levodopa-equivalent dose of less than 1000 mg and a good response to levodopa have been shown to be predictive factors for good clinical outcome in pallidotomy. 4, 18 In addition, although this has not been explicitly confirmed in pallidal stimulation studies, we believe that our patients were excellent candidates for good outcomes, on the basis of strict selection criteria.
Conclusions
Unilateral pallidal stimulation is a safe procedure that conveys a beneficial effect, in the short term, on motor symptoms that are contralateral as well as ipsilateral to the side of the stimulation. Long-term results, however, are unsatisfactory, meaning that this procedure is not a valid treatment option for patients with advanced PD.
